The cannabinoid acids, analogs and endogenous counterparts
about
Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.Ajulemic acid: potential treatment for chronic inflammation.
P2860
The cannabinoid acids, analogs and endogenous counterparts
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The cannabinoid acids, analogs and endogenous counterparts
@ast
The cannabinoid acids, analogs and endogenous counterparts
@en
The cannabinoid acids, analogs and endogenous counterparts
@nl
type
label
The cannabinoid acids, analogs and endogenous counterparts
@ast
The cannabinoid acids, analogs and endogenous counterparts
@en
The cannabinoid acids, analogs and endogenous counterparts
@nl
prefLabel
The cannabinoid acids, analogs and endogenous counterparts
@ast
The cannabinoid acids, analogs and endogenous counterparts
@en
The cannabinoid acids, analogs and endogenous counterparts
@nl
P2860
P1476
The cannabinoid acids, analogs and endogenous counterparts
@en
P2093
Sumner H. Burstein
P2860
P304
P356
10.1016/J.BMC.2014.03.038
P407
P577
2014-05-15T00:00:00Z